David E. Seitz

1.4k total citations
39 papers, 1.1k citations indexed

About

David E. Seitz is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, David E. Seitz has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Organic Chemistry, 12 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in David E. Seitz's work include Chemical Synthesis and Analysis (5 papers), Chemical Synthesis and Reactions (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). David E. Seitz is often cited by papers focused on Chemical Synthesis and Analysis (5 papers), Chemical Synthesis and Reactions (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). David E. Seitz collaborates with scholars based in United States, United Kingdom and China. David E. Seitz's co-authors include Robert N. Hanson, Jeffrey C. Bottaro, Antonio Zapata, Barry L. Karger, Geoffrey Davies, J. N. LePage, Wolfgang Lindner, James A. Marshall, James J. Rusthoven and Sally P. Stabler and has published in prestigious journals such as Journal of the American Chemical Society, Analytical Chemistry and The Journal of Organic Chemistry.

In The Last Decade

David E. Seitz

37 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David E. Seitz United States 17 338 294 257 204 135 39 1.1k
Göran Claeson United Kingdom 21 367 1.1× 404 1.4× 165 0.6× 191 0.9× 89 0.7× 49 1.5k
Thomas R. Tritton United States 25 151 0.4× 1.1k 3.6× 572 2.2× 144 0.7× 100 0.7× 53 1.8k
Marina I. Nelen United States 17 472 1.4× 488 1.7× 95 0.4× 120 0.6× 195 1.4× 27 1.2k
Kevin Shreder United States 18 329 1.0× 587 2.0× 145 0.6× 54 0.3× 223 1.7× 40 1.0k
Karl A. Koehler United States 19 149 0.4× 693 2.4× 163 0.6× 57 0.3× 229 1.7× 72 1.2k
Takashi Kawamura Japan 18 450 1.3× 191 0.6× 230 0.9× 110 0.5× 28 0.2× 70 1.2k
Mervyn Israel United States 28 608 1.8× 1.3k 4.4× 822 3.2× 106 0.5× 81 0.6× 116 2.5k
Giuseppina Di Stefano Italy 29 268 0.8× 1.3k 4.4× 425 1.7× 87 0.4× 94 0.7× 101 2.3k
Masateru Ohta Japan 17 128 0.4× 305 1.0× 330 1.3× 228 1.1× 25 0.2× 75 1.2k
Jan Čejka Czechia 19 350 1.0× 261 0.9× 78 0.3× 61 0.3× 178 1.3× 120 1.3k

Countries citing papers authored by David E. Seitz

Since Specialization
Citations

This map shows the geographic impact of David E. Seitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Seitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Seitz more than expected).

Fields of papers citing papers by David E. Seitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Seitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Seitz. The network helps show where David E. Seitz may publish in the future.

Co-authorship network of co-authors of David E. Seitz

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Seitz. A scholar is included among the top collaborators of David E. Seitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Seitz. David E. Seitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choi, Yongki, Issa S. Moody, Patrick C. Sims, et al.. (2012). Single-Molecule Dynamics of Lysozyme Processing Distinguishes Linear and Cross-Linked Peptidoglycan Substrates. Journal of the American Chemical Society. 134(4). 2032–2035. 35 indexed citations
2.
Choi, Yongki, Issa S. Moody, Patrick C. Sims, et al.. (2012). Correction to Single-Molecule Dynamics of Lysozyme Processing Distinguishes Linear and Cross-Linked Peptidoglycan Substrates. Journal of the American Chemical Society. 134(19). 8286–8286. 2 indexed citations
3.
Hanna, Nasser H., et al.. (2003). Phase I Trial of Carboplatin and Paclitaxel With Escalating Doses of Oral Topotecan in Patients With Solid Tumors. American Journal of Clinical Oncology. 26(2). 200–202. 3 indexed citations
4.
Schneider, Bryan P., Kristen N. Ganjoo, David E. Seitz, et al.. (2003). Phase II Study of Gemcitabine plus Docetaxel in Advanced Pancreatic Cancer: A Hoosier Oncology Group Study. Oncology. 65(3). 218–223. 39 indexed citations
5.
Hanna, Nasser H., et al.. (2003). Phase I Trial of Carboplatin and Paclitaxel With Escalating Doses of Oral Topotecan in Patients With Solid Tumors. American Journal of Clinical Oncology. 26(2). 200–202. 1 indexed citations
6.
Niyikiza, Clet, Sharyn D. Baker, David E. Seitz, et al.. (2002). Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy.. PubMed. 1(7). 545–52. 218 indexed citations
7.
8.
Munshi, Nikhil C., David E. Seitz, Frank V. Fossella, Scott M. Lippman, & Lawrence H. Einhorn. (1993). Phase II study of sulofenur (LY 186641). Investigational New Drugs. 11(1). 87–90. 13 indexed citations
9.
Fossella, Frank V., Scott M. Lippman, David E. Seitz, et al.. (1991). Hypoprothrombinemia from coadministration of sulofenur (LY 186641) and warfarin: Report of three cases. Investigational New Drugs. 9(4). 357–359. 2 indexed citations
10.
Blaszczak, Larry C., et al.. (1989). Radioiododestannylation. Convenient synthesis of a stable penicillin derivative for rapid penicillin binding protein (PBP) assay. Journal of Labelled Compounds and Radiopharmaceuticals. 27(4). 401–406. 26 indexed citations
11.
Seitz, David E., Richard A. Milius, & James Quick. (1982). Macrolide closure via fluorodesilylation a total synthesis of d, 1-17-o-methyllythridine. Tetrahedron Letters. 23(14). 1439–1442. 4 indexed citations
12.
Hanson, Robert N. & David E. Seitz. (1982). Tissue distribution of the radiolabeled antiestrogen [125I]iodotamoxifen. International Journal of Nuclear Medicine and Biology. 9(2). 105–107. 8 indexed citations
13.
Hanson, Robert N., et al.. (1982). E-17 alpha[125I]iodovinylestradiol: an estrogen-receptor-seeking radiopharmaceutical.. PubMed. 23(5). 431–6. 56 indexed citations
14.
Seitz, David E., et al.. (1981). Tritiodestannylation. Synthesis of a Specifically Labelled [3H]Tamoxifen. Synthetic Communications. 11(4). 281–286. 11 indexed citations
15.
Bottaro, Jeffrey C., Robert N. Hanson, & David E. Seitz. (1981). Simple and direct synthesis of trans-1,2-bis(tributylstannyl)ethylene. The Journal of Organic Chemistry. 46(25). 5221–5222. 54 indexed citations
16.
Hanson, Robert N., et al.. (1981). Position-specific radioiodination utilizing an aryltributylstannyl intermediate. Synthesis of 125I-iodotamoxifen. The International Journal of Applied Radiation and Isotopes. 32(3). 171–173. 23 indexed citations
17.
Seitz, David E. & Antonio Zapata. (1981). Tributyl-(trimethylsilylmethyl)-tin: Synthesis of 2-Oxoalkylsilanes (Silylmethyl Ketones) via Transmetallation. Synthesis. 1981(7). 557–558. 18 indexed citations
18.
Seitz, David E., Felix E. Granchelli, & John L. Neumeyer. (1977). Sulfenylation and Halogenation of Di-and Trianions Derived from Substituted Glutarimides. Synthetic Communications. 7(6). 367–374. 3 indexed citations
19.
Marshall, James A. & David E. Seitz. (1975). Cleavage-elimination of 2,3-decalindione monothioketals leading to vinylic ester and lactone prototypes of vernolepin. The Journal of Organic Chemistry. 40(4). 534–536. 14 indexed citations
20.
Marshall, James A., Charles T. Buse, & David E. Seitz. (1973). The Hydroxide-Initiated Cleavage of α-Diketone Monothioketals. Synthetic Communications. 3(1). 85–88. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Göran Claeson Breakdown of academic impact, for papers by Thomas R. Tritton Breakdown of academic impact, for papers by Marina I. Nelen Breakdown of academic impact, for papers by Kevin Shreder Breakdown of academic impact, for papers by Karl A. Koehler Breakdown of academic impact, for papers by Takashi Kawamura Breakdown of academic impact, for papers by Mervyn Israel Breakdown of academic impact, for papers by Giuseppina Di Stefano Breakdown of academic impact, for papers by Masateru Ohta Breakdown of academic impact, for papers by Jan Čejka
Rankless by CCL
2026